首页> 外文期刊>Current opinion in urology >Neurogenic bladder dysfunction in patients with myelomeningocele.
【24h】

Neurogenic bladder dysfunction in patients with myelomeningocele.

机译:脊髓膜脑膨出患者的神经源性膀胱功能障碍。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE OF REVIEW The general management strategies in children with myelodysplasia are widely accepted, however diagnostic and therapeutic details still need to be discussed and clarified.RECENT FINDINGS Ten articles are reviewed. Two articles are dealing with general clinical aspects; one underlines the need for urodynamics as a prerequisite for an adaequate treatment strategy, the other recommends to evaluate adolescents and adults with myelodysplasia, because only the ultimate outcome allows a judgement of how effective our efforts are to achieve the goals. Increased excretion of glycosaminoglycan in myelodysplasia children above 5 years of age could become a marker for beginning bladder damage and deserves further interest. The question whether children with normal urodynamics after closing the spinal cord should be followed or not is clearly answered in a further article which also discusses the results of detethering in these patients. Four articles report on pharmacotherapy with new substances or new ways of application (intravesical oxybutynin, extended release oxybutynin formulation, intravesical resiniferatoxin). The results of collagen injections in children with neurogenic sphincter underactivity clearly demonstrate that the long-term results are disappointing. Last, but not least, a retrospective review on acute abdominal symptoms and signs in children with myelodysplasia clearly shows that these patients should be transferred to a centre because of complex reasons and treatment modalities.SUMMARY Urodynamics - abnormal or normal - are a prerequisite for adaequate treatment and follow-up in children with myelodysplasia. More studies should focus on adolescents and adults with myelodysplasia to judge the effectiveness of our diagnostic and therapeutic efforts. New ways of application and new developments in pharmacotherapy to relax the overactive detrusor may possibly further decrease the need for surgery in the future. With regards to sphincter underactivity, results with collagen injections in this group of patients are disappointing and provide no alternative to operative treatment options.
机译:审查的目的骨髓增生异常儿童的一般治疗策略已被广泛接受,但是诊断和治疗的细节仍需讨论和阐明。最新发现综述了十篇文章。有两篇文章涉及一般的临床问题;一个强调需要尿动力学作为适当治疗策略的先决条件,另一个建议评估青少年和成年骨髓增生异常的成年人,因为只有最终的结果才能判断我们为达到目标所进行的努力是否有效。 5岁以上儿童骨髓增生异常中糖胺聚糖排泄的增加可能成为开始膀胱损害的标志,值得进一步关注。在另一篇文章中也清楚地回答了是否应该遵循在关闭脊髓后尿动力学正常的儿童的问题,该文章还讨论了对这些患者进行束缚的结果。有四篇文章报道了使用新物质或新应用方式(膀胱内奥昔布宁,缓释奥昔布宁制剂,膀胱内树脂毒素)进行药物治疗的报道。神经性括约肌功能不全患儿注射胶原蛋白的结果清楚地表明,长期结果令人失望。最后但并非最不重要的是,对骨髓增生异常儿童急性腹部症状和体征的回顾性研究清楚表明,由于复杂的原因和治疗方式,这些患者应转移至中心。总结尿动力学-异常或正常-是适当适应的先决条件骨髓增生异常儿童的治疗和随访。更多研究应集中在青少年和成年骨髓增生异常,以判断我们的诊断和治疗努力的有效性。放松过度活跃的逼尿肌的药物治疗的新应用方式和新发展可能会在未来进一步减少手术需求。关于括约肌活动不足,在这组患者中注射胶原蛋白的结果令人失望,并且不能替代手术治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号